(Q51500147)

English

Comparison of the effects of fasting morning, fasting evening and fed bedtime administration of tenatoprazole on intragastric pH in healthy volunteers: a randomized three-way crossover study.

scientific article published in April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/16611279

Comparison of the effects of fasting morning, fasting evening and fed bedtime administration of tenatoprazole on intragastric pH in healthy volunteers: a randomized three-way crossover study. (English)

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/16611279

1 reference

based on heuristic

inferred from title

author name string

A B R Thomson

1

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/16611279

P Cohen

2

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/16611279

H Ficheux

3

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/16611279

P Fiorentini

4

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/16611279

F Domagala

5

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/16611279

M Homerin

6

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/16611279

A Taccoen

7

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/16611279

language of work or name

0 references

publication date

1 April 2006

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/16611279

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/16611279

23

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/16611279

8

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/16611279

1179-1187

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/16611279

Rabeprazole 10 mg twice daily is superior to 20 mg once daily for night-time gastric acid suppression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02781.X

21 January 2018

Intragastric acid suppression and pharmacokinetics of twice-daily esomeprazole: a randomized, three-way crossover study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02781.X

21 January 2018

Effect of splitting the dose of esomeprazole on gastric acidity and nocturnal acid breakthrough

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02781.X

21 January 2018

The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02781.X

21 January 2018

Chemistry of covalent inhibition of the gastric (H+, K+)-ATPase by proton pump inhibitors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02781.X

21 January 2018

Tenatoprazole, a novel proton pump inhibitor with a prolonged plasma half-life: effects on intragastric pH and comparison with esomeprazole in healthy volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02781.X

21 January 2018

A comparative study of the early effects of tenatoprazole 40 mg and esomeprazole 40 mg on intragastric pH in healthy volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02781.X

21 January 2018

Effect on intragastric pH of a PPI with a prolonged plasma half-life: comparison between tenatoprazole and esomeprazole on the duration of acid suppression in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02781.X

21 January 2018

Different patterns of oesophageal acid exposure distinguish complicated reflux disease from either erosive reflux oesophagitis or non-erosive reflux disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02781.X

21 January 2018

Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02781.X

21 January 2018

An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02781.X

21 January 2018

Comparison of morning and evening administration of rabeprazole for gastro‐oesophageal reflux and nocturnal gastric acid breakthrough in patients with reflux disease: a double‐blind, cross‐over study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02781.X

21 January 2018

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2006.02781.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2006.02781.X

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/16611279

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/16611279

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51500147&oldid=1546730034"